KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organon (OGN) Treasury Shares (2021 - 2025)

Historic Treasury Shares for Organon (OGN) over the last 5 years, with Q3 2025 value amounting to $9.7 million.

  • Organon's Treasury Shares fell 9988.49% to $9.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.7 million, marking a year-over-year decrease of 9988.49%. This contributed to the annual value of $8.6 million for FY2024, which is 1436.56% up from last year.
  • Per Organon's latest filing, its Treasury Shares stood at $9.7 million for Q3 2025, which was down 9988.49% from $9.8 million recorded in Q2 2025.
  • Over the past 5 years, Organon's Treasury Shares peaked at $9.6 billion during Q1 2024, and registered a low of $3.3 million during Q3 2021.
  • Over the past 5 years, Organon's median Treasury Shares value was $4.1 billion (recorded in 2022), while the average stood at $3.8 billion.
  • Its Treasury Shares has fluctuated over the past 5 years, first soared by 13905875.67% in 2023, then crashed by 9988.75% in 2025.
  • Quarter analysis of 5 years shows Organon's Treasury Shares stood at $3.3 billion in 2021, then soared by 53.9% to $5.0 billion in 2022, then crashed by 99.85% to $7.5 million in 2023, then increased by 14.37% to $8.6 million in 2024, then increased by 12.46% to $9.7 million in 2025.
  • Its Treasury Shares stands at $9.7 million for Q3 2025, versus $9.8 million for Q2 2025 and $10.8 million for Q1 2025.